is semaglutide off patent Novo Nordisk losing Canadian protection on a blockbuster drug after not paying a small fee Everyone talked about Ozempic. Few

Maciejewska, K., Czarnecka, K

Many people prefer injecting in the evening so that any initial nausea from the dose occurs while they sleep

Future research should examine, prospectively, the relationship between OSA and type 2 diabetes diagnosis and long-term outcomes of GLP-1 therapy

The company is fighting on behalf of patients who deserve to know what they are injecting into their bodies

In many people with diabetes or ongoing weight struggles, these natural signals dont last long enough to be effective

Myostatin inhibitors like apitegromab show early promise for preserving lean mass during GLP-1-assisted weight loss, but havent yet proven they preserve functional strength